๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure

โœ Scribed by Sonja Merkesdal; Timm Kirchhoff; Diane Wolka; Gunter Ladinek; Adrian Kielhorn; Andrea Rubbert-Roth


Publisher
Springer
Year
2009
Tongue
French
Weight
293 KB
Volume
11
Category
Article
ISSN
1618-7598

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A cost-effectiveness analysis of treatme
โœ Hyon K. Choi; John D. Seeger; Karen M. Kuntz ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 2 views

## Objective: Recently, new treatment options for rheumatoid arthritis (ra) patients with an inadequate response to methotrexate (mtx) have become available. given the wide variability in efficacy and costs among these different treatment options, we sought to determine their cost-effectiveness (ce